Endpoint Clinical acquires Bluefin to expand clinical supply planning
AI Summary- Endpoint Clinical acquired Bluefin to enter clinical supply forecasting and planning.
- Bluefin will operate independently and remain compatible with RTSM systems across the industry.
- Arsenal Capital Partners acquired Endpoint Clinical in 2024 and continues supporting its growth.